{"log_id": 6116583094675388076, "direction": 0, "words_result_num": 23, "words_result": [{"probability": {"variance": 0.000558, "average": 0.994331, "min": 0.85183}, "location": {"width": 813, "top": 198, "height": 79, "left": 211}, "words": "HOPE研究是一项双盲、随机、安慰剂/活性药物对照,针对有完整子宫的健康绝经后"}, {"probability": {"variance": 0.001715, "average": 0.986944, "min": 0.785503}, "location": {"width": 846, "top": 229, "height": 79, "left": 163}, "words": "妇女进行的多中心研究。受试者(平均年龄53.3±4.9岁)平均绝经年限2.3±0.9年,每"}, {"probability": {"variance": 0.001506, "average": 0.989517, "min": 0.749121}, "location": {"width": 862, "top": 258, "height": 81, "left": 164}, "words": "天服用一片含600mng钙元素的钙片(钙尔奇)。受试者没有补充维生素D。她们分别接受"}, {"probability": {"variance": 0.000324, "average": 0.991374, "min": 0.900452}, "location": {"width": 821, "top": 290, "height": 80, "left": 164}, "words": "倍美力0.625mg、0.45mg、0.3mg或安慰剂治疗。骨丢失的预防是通过测量骨矿密度"}, {"probability": {"variance": 0.000663, "average": 0.990246, "min": 0.848041}, "location": {"width": 784, "top": 319, "height": 80, "left": 186}, "words": "BMD)来评价的,主要是从前后位测量腰椎(L2至L4)。其次,还要检测全身的"}, {"probability": {"variance": 0.003756, "average": 0.985099, "min": 0.59714}, "location": {"width": 864, "top": 347, "height": 80, "left": 166}, "words": "BMD,也分析股骨颈和股骨转子的BMD。在第6、13、19和26个周期,血清骨钙素、尿"}, {"probability": {"variance": 6.4e-05, "average": 0.995195, "min": 0.970667}, "location": {"width": 413, "top": 402, "height": 55, "left": 168}, "words": "钙和N末端肽被作为骨转换的指标(BTM"}, {"probability": {"variance": 0.000101, "average": 0.995941, "min": 0.939234}, "location": {"width": 815, "top": 459, "height": 78, "left": 220}, "words": "第6、13、19和26个周期时,在全部4个BMD终点,所有的活性药物治疗组与安慰"}, {"probability": {"variance": 1e-06, "average": 0.999224, "min": 0.996375}, "location": {"width": 159, "top": 472, "height": 40, "left": 171}, "words": "意向治疗受试者"}, {"probability": {"variance": 0.000331, "average": 0.995289, "min": 0.886494}, "location": {"width": 846, "top": 490, "height": 78, "left": 173}, "words": "剂组相比都有显著性差异。在最终的治疗评估(完成者的第26个周期和提前退出者所能"}, {"probability": {"variance": 0.000183, "average": 0.992427, "min": 0.955782}, "location": {"width": 400, "top": 546, "height": 51, "left": 173}, "words": "提供的最后一次评估),百要有效性指标"}, {"probability": {"variance": 0.003489, "average": 0.972261, "min": 0.809166}, "location": {"width": 361, "top": 520, "height": 48, "left": 655}, "words": "BM)平均增加百分比在0.625mg组"}, {"probability": {"variance": 0.003116, "average": 0.981352, "min": 0.619884}, "location": {"width": 850, "top": 547, "height": 80, "left": 176}, "words": "为2.46%,0.45mg组为2.26%,0.3mg组为1.13%。在最后评估时,安慰剂组与基线相比"}, {"probability": {"variance": 0.007464, "average": 0.975973, "min": 0.506371}, "location": {"width": 845, "top": 576, "height": 79, "left": 177}, "words": "平均百分数下降2.45‰。这些结果表明低剂量倍美力与安慰剂相比可以有效增加L2到L"}, {"probability": {"variance": 0.0001, "average": 0.996358, "min": 0.957839}, "location": {"width": 346, "top": 635, "height": 51, "left": 178}, "words": "的BMD,因此支持低剂量的有效性"}, {"probability": {"variance": 0.000267, "average": 0.994913, "min": 0.907725}, "location": {"width": 807, "top": 660, "height": 76, "left": 230}, "words": "分析其它3个BMD的终点结果表明,相对于基线,股骨转子的平均百分数变化较L2"}, {"probability": {"variance": 0.003435, "average": 0.983613, "min": 0.706214}, "location": {"width": 839, "top": 690, "height": 78, "left": 184}, "words": "一L4的变化大,而股骨颈和全身的平均百分数变化比L2-L4的变化小。组间的显著性差"}, {"probability": {"variance": 0.020195, "average": 0.94462, "min": 0.450491}, "location": {"width": 860, "top": 719, "height": 77, "left": 181}, "words": "异提示每种剂量的倍美力治疗对另外的3个BMD终点都比安慰剂更有效在股常颚和全"}, {"probability": {"variance": 0.01292, "average": 0.967555, "min": 0.366116}, "location": {"width": 893, "top": 749, "height": 114, "left": 180}, "words": "骨转子,每个倍美力剂量组平均百分数增加值都显著大于安慰剂组的小幅度增加。最终"}, {"probability": {"variance": 0.015395, "average": 0.962814, "min": 0.419884}, "location": {"width": 848, "top": 750, "height": 75, "left": 183}, "words": "身的BMD,活性药物治疗组显示出平均百分数增加,而安慰剂组平均百分数降。丝"}, {"probability": {"variance": 1e-06, "average": 0.999316, "min": 0.997379}, "location": {"width": 353, "top": 834, "height": 50, "left": 184}, "words": "评估相对基线的变化百分比见于表4"}, {"probability": {"variance": 0, "average": 0.849643, "min": 0.849643}, "location": {"width": 35, "top": 854, "height": 32, "left": 743}, "words": "令"}, {"probability": {"variance": 0.000157, "average": 0.993129, "min": 0.968106}, "location": {"width": 181, "top": 819, "height": 80, "left": 895}, "words": "西药商务部"}], "language": 3}